NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)

NEXTURNBIOSCIENCE Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21,730	10,602	13,737	10,644	20,632	52,700
Short-Term Investments	6,025	5,570	2,260	12,425	11,500	-
Trading Asset Securities	26,306	19,690	15,144	5,078	9,051	1,260
Cash & Short-Term Investments	54,061	35,863	31,141	28,147	41,184	53,960
Cash Growth	49.52%	15.16%	10.64%	-31.66%	-23.68%	809.25%
Accounts Receivable	7,699	3,347	6,713	5,963	2,753	3,085
Other Receivables	1,370	1,117	958.61	2,081	1,229	-
Receivables	11,178	8,622	8,701	8,353	4,301	4,788
Inventory	29,837	8,438	6,247	7,023	5,352	6,982
Prepaid Expenses	469.55	67.35	75.47	121.12	51.8	19.25
Other Current Assets	316.97	117.25	612.59	322.12	57.62	1,037
Total Current Assets	95,863	53,107	46,777	43,966	50,946	66,786
Property, Plant & Equipment	51,693	27,227	27,955	28,628	12,662	16,043
Long-Term Investments	64,193	65,722	83,476	42,099	55,221	3,650
Goodwill	1,656	1,656	1,656	1,656	-	-
Other Intangible Assets	1,903	993.89	1,168	2,205	123.23	136.15
Long-Term Accounts Receivable	82,752	82,213	81,191	80,238	-	-
Long-Term Deferred Tax Assets	-	-	-	-	509.21	798.98
Long-Term Deferred Charges	0	0	0	0	0	0
Other Long-Term Assets	55,162	2,081	1,771	1,466	19,487	11,937
Total Assets	353,318	233,037	243,994	200,257	138,949	99,351
Accounts Payable	3,219	2,059	2,882	4,147	946.83	717.07
Accrued Expenses	971.89	377.72	555.68	593.37	236.14	118.81
Short-Term Debt	15,867	16,096	10,846	8,236	25,456	-
Current Portion of Long-Term Debt	64,000	-	64,375	625	-	-
Current Portion of Leases	908.71	874.01	798.78	803.49	732.96	22.52
Current Income Taxes Payable	138.84	322.47	3,274	8.2	127.62	-
Current Unearned Revenue	109.83	32.62	87.83	42.71	-	40.02
Other Current Liabilities	10,438	3,072	10,854	5,246	15,718	1,170
Total Current Liabilities	95,653	22,833	93,672	19,702	43,218	2,069
Long-Term Debt	11,400	64,000	-	64,375	-	-
Long-Term Leases	1,013	253.39	749.74	1,519	2,186	17.87
Long-Term Deferred Tax Liabilities	8,207	4,058	6,553	2,046	-	-
Other Long-Term Liabilities	1,510	5,269	5,006	3,922	578.85	304.8
Total Liabilities	120,588	96,413	105,981	91,983	46,214	2,583
Common Stock	34,314	30,427	23,509	19,427	16,610	5,923
Additional Paid-In Capital	65,954	65,394	61,033	45,093	35,733	46,494
Retained Earnings	49,240	39,723	53,083	43,821	46,734	51,341
Treasury Stock	-81.25	-81.25	-81.25	-	-6,990	-6,990
Comprehensive Income & Other	1,092	1,161	470	-66.18	646.76	-0
Shareholders' Equity	232,730	136,624	138,014	108,274	92,735	96,768
Total Liabilities & Equity	353,318	233,037	243,994	200,257	138,949	99,351
Total Debt	93,188	81,223	76,769	75,558	28,375	40.39
Net Cash (Debt)	-39,127	-45,361	-45,628	-47,412	12,808	53,920
Net Cash Growth	-	-	-	-	-76.25%	808.57%
Net Cash Per Share	-3217.94	-4149.54	-4523.61	-6984.29	1997.46	8408.77
Filing Date Shares Outstanding	13.72	12.16	9.4	7.77	6.41	6.41
Total Common Shares Outstanding	13.72	12.16	9.4	7.77	6.41	6.41
Working Capital	209.59	30,274	-46,895	24,264	7,728	64,717
Book Value Per Share	10971.49	11231.71	14686.92	13933.75	14462.04	15090.95
Tangible Book Value	146,962	133,974	135,190	104,414	92,612	96,632
Tangible Book Value Per Share	10712.11	11013.90	14386.39	13436.98	14442.82	15069.72
Land	33,921	19,143	19,143	19,143	5,013	9,767
Buildings	13,381	7,938	7,938	8,071	4,426	6,661
Machinery	2,579	9,942	9,625	11,114	5,451	5,497
Construction In Progress	146.65	-	82.5	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.